TY - JOUR
T1 - Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound
AU - Zocco, Maria Assunta
AU - Garcovich, Matteo
AU - Lupascu, Andrea
AU - Di Stasio, Enrico
AU - Roccarina, Davide
AU - Annicchiarico, Brigida Eleonora
AU - Riccardi, Laura
AU - Ainora, Maria Elena
AU - Ponziani, Francesca Romana
AU - Caracciolo, Gianluigi
AU - Rapaccini, Gian Ludovico
AU - Landolfi, Raffaele
AU - Siciliano, Massimo
AU - Pompili, Maurizio
AU - Gasbarrini, Antonio
PY - 2013
Y1 - 2013
N2 - Sorafenib has become the standard first-line treatment for patients with advanced HCC and acts by inducing alterations in tumor vascularity. We wanted to evaluate the feasibility of dynamic CEUS (D-CEUS) as a predictor of early tumor response to sorafenib and to correlate functional parameters with clinical efficacy end points.
AB - Sorafenib has become the standard first-line treatment for patients with advanced HCC and acts by inducing alterations in tumor vascularity. We wanted to evaluate the feasibility of dynamic CEUS (D-CEUS) as a predictor of early tumor response to sorafenib and to correlate functional parameters with clinical efficacy end points.
KW - Dynamic contrast enhanced ultrasound
KW - Hepatocellular carcinoma
KW - Sorafenib
KW - Tumour response
KW - Dynamic contrast enhanced ultrasound
KW - Hepatocellular carcinoma
KW - Sorafenib
KW - Tumour response
UR - http://hdl.handle.net/10807/52141
U2 - 10.1016/j.jhep.2013.06.011
DO - 10.1016/j.jhep.2013.06.011
M3 - Article
SN - 0168-8278
VL - 59
SP - 1014
EP - 1021
JO - Journal of Hepatology
JF - Journal of Hepatology
ER -